BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$2.69B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.49B |
| 3 |
Corteva
CTVA
|
+$1.57B |
| 4 |
Alibaba
BABA
|
+$1.18B |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.08B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$2.29B |
| 2 |
Apple
AAPL
|
+$1.42B |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.06B |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$957M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$888M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.94% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 13.61% |
| 4 | Consumer Discretionary | 10.17% |
| 5 | Industrials | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4176
Oramed Pharmaceuticals
ORMP
$169M
| $267K | ﹤0.01% |
74,291
+2,423
| +3% | +$8.55K |
|
4177
DLH Holdings
DLHC
$71M
| $264K | ﹤0.01% |
51,987
+25,275
| +95% | +$142K |
|
|
KEG
4178
DELISTED
Key Energy Services, Inc. Common Stock
KEG
| $264K | ﹤0.01% |
117,545
-353,038
| -75% | -$1.06M |
|
4179
Ovid Therapeutics
OVID
$442M
| $261K | ﹤0.01% |
141,062
-525,838
| -79% | -$939K |
|
4180
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.5B
| $260K | ﹤0.01% |
981
-5
| -0.5% | -$1.3K |
|
|
NOVN
4181
DELISTED
Novan, Inc. Common Stock
NOVN
| $260K | ﹤0.01% |
9,599
+4,930
| +106% | +$84.5K |
|
4182
Jakks Pacific
JAKK
$302M
| $254K | ﹤0.01% |
36,204
-5,050
| -12% | -$44.7K |
|
4183
Rocky Mountain Chocolate Factory
RMCF
$8.12M
| $254K | ﹤0.01% |
30,311
+1,831
| +6% | +$17K |
|
|
ATXI
4184
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $251K | ﹤0.01% |
35
+20
| +133% | +$116K |
|
4185
Air T
AIRT
$75.4M
| $249K | ﹤0.01% |
14,242
-296
| -2% | -$5.43K |
|
|
TA
4186
DELISTED
TravelCenters of America LLC
TA
| $249K | ﹤0.01% |
13,743
+2,617
| +24% | +$50.1K |
|
|
VIVE
4187
DELISTED
VIVEVE MED INC
VIVE
| $249K | ﹤0.01% |
654
-89
| -12% | -$48.3K |
|
4188
First US Bancshares
FUSB
$93M
| $247K | ﹤0.01% |
26,711
+2,381
| +10% | +$23.1K |
|
|
AGRX
4189
DELISTED
Agile Therapeutics
AGRX
| $247K | ﹤0.01% |
85
+18
| +27% | +$50.3K |
|
|
GVP
4190
DELISTED
GSE Systems, Inc.
GVP
| $245K | ﹤0.01% |
10,447
+728
| +7% | +$17.9K |
|
4191
Fortuna Silver Mines
FSM
$2.66B
| $236K | ﹤0.01% |
+82,664
| New | +$239K |
|
4192
Invesco FTSE RAFI US 1000 ETF
PRF
$9.78B
| $234K | ﹤0.01% |
10,040
-245
| -2% | -$5.63K |
|
|
APLT
4193
DELISTED
Applied Therapeutics
APLT
| $228K | ﹤0.01% |
+27,704
| New | +$262K |
|
4194
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.11B
| $226K | ﹤0.01% |
4,494
+1,435
| +47% | +$71.6K |
|
|
FLNA
4195
Filana Therapeutics
FLNA
$46.4M
| $226K | ﹤0.01% |
187,263
-36,706
| -16% | -$41.6K |
|
4196
Vivani Medical
VANI
$112M
| $226K | ﹤0.01% |
11,766
-2,413
| -17% | -$49.5K |
|
4197
Ark Restaurants
ARKR
$20.4M
| $224K | ﹤0.01% |
10,932
+904
| +9% | +$18.2K |
|
|
FNJN
4198
DELISTED
Finjan Holdings, Inc.
FNJN
| $224K | ﹤0.01% |
100,804
+50,657
| +101% | +$136K |
|
|
ARTX
4199
DELISTED
Arotech Corporation
ARTX
| $224K | ﹤0.01% |
112,810
+35,020
| +45% | +$87.6K |
|
4200
Arcturus Therapeutics
ARCT
$168M
| $222K | ﹤0.01% |
23,548
+4,480
| +23% | +$32.9K |
|
Similar funds
BlackRock's Q2 2019 Portfolio in Review
As of Q2 2019, BlackRock held 5,206 positions worth $2.34T, up 4.4% from $2.24T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q2 2019 filing shows 233 new, 2,845 increased, 1,535 reduced and 146 closed positions. Its largest new stake was Dow Inc: 50,959,336 shares worth $2.51B. The largest sale was DuPont de Nemours, an estimated $2.29B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q2 2019 buy was Dow Inc: 50,959,336 shares worth $2.51B.
- BlackRock added most to iShares MSCI EAFE ETF in Q2 2019, an estimated $2.49B increase.
- BlackRock's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $2.29B.
- BlackRock fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $957M.
- BlackRock's ten largest holdings make up 15% of its $2.34T portfolio in Q2 2019.
- BlackRock opened 233 new positions and closed 146 in Q2 2019.
- BlackRock's portfolio value rose 4.4% quarter-over-quarter to $2.34T.
Based on BlackRock's 13F filing for Q2 2019, filed 13 Aug 2019.